Year archive

Nykode Therapeutics ASA — 2020 filings

All 25 regulatory filings released by Nykode Therapeutics ASA (NYKD) in 2020, sourced directly from the official regulator.

25 Filings

2020 Period

2020 filings (25)

Filing	Released	Lang
Share capital increase from exercise of warrants Share Issue/Capital Change	2020-12-30	English
Vaccibody - Mandatory notification of intra group transfer of shares by primary insider Major Shareholding Notification	2020-12-11	English
Mandatory notification of intra group transfer of shares by primary insider’s related party Major Shareholding Notification	2020-12-10	English
Vaccibody reports promising preclinical data with a second-generation COVID-19 vaccine and announces its infectious disease strategy Regulatory Filings	2020-12-10	English
Vaccibody reports promising preclinical data with a second-generation COVID-19 vaccine and announces its infectious disease strategy Regulatory Filings	2020-12-10	English
Mandatory notification of exercise of warrants and acquisition of shares by primary insiders Share Issue/Capital Change	2020-12-09	English
Mandatory notification of exercise of warrants and acquisition of shares by primary insiders Share Issue/Capital Change	2020-12-08	English
Vaccibody AS – Quarterly report 3Q 2020 Interim / Quarterly Report 9M 2020	2020-11-17	English
Vaccibody AS – Quarterly report 3Q 2020 Report Publication Announcement Q3 2020	2020-11-17	English
Mandatory notification of trade - party related to primary insider Director's Dealing	2020-11-12	English
Vaccibody to present at Jefferies Virtual Healthcare Conference (November 17-19, 2020) Report Publication Announcement	2020-11-12	English
Vaccibody to present at Jefferies Virtual Healthcare Conference (November 17-19, 2020) Regulatory Filings	2020-11-12	English
Vaccibody announces the closing of the worldwide license and collaboration agreement with Genentech Capital/Financing Update	2020-11-06	English
Vaccibody announces the closing of the worldwide license and collaboration agreement with Genentech Capital/Financing Update	2020-11-06	English
MANDATORY NOTIFICATION OF TRADE - PRIMARY INSIDER Director's Dealing	2020-10-22	English
Share capital increase from exercise of warrants Share Issue/Capital Change	2020-10-21	English
MANDATORY NOTIFICATION OF TRADE - PRIMARY INSIDER Director's Dealing	2020-10-07	English
Vaccibody AS Lists on Oslo Stock Exchange’s Merkur Market Share Issue/Capital Change	2020-10-07	English
Vaccibody AS Lists on Oslo Stock Exchange’s Merkur Market Share Issue/Capital Change	2020-10-07	English
Oslo Børs –Vaccibody AS - Nytt selskap tas opp til handel på Merkur Market 07.10.2020 / New company admitted to trading on Merkur Market 07.10.2020. Delisting Announcement	2020-10-07	Norwegian
Financial calendar Report Publication Announcement	2020-10-07	English
Vaccibody AS: Publication of Admission Document Regulatory Filings	2020-10-07	English
Vaccibody AS: Publication of Admission Document Regulatory Filings	2020-10-07	English
Oslo Børs –Vaccibody AS - Nytt selskap tas opp til handel på Merkur Market 07.10.2020 / New company admitted to trading on Merkur Market 07.10.2020. Delisting Announcement	2020-10-06	Norwegian
Merkur Market - Received application for admission to trading – Vaccibody AS Delisting Announcement	2020-10-06	English